Perioperative medicine & outcomes

The association between preoperative serum cholinesterase and all-cause mortality in geriatric patients with hip fractures: a cohort study of 2387 patients

Perioper Med (Lond)Published Cohort study

Authors' conclusion

Preoperative cholinesterase levels were nonlinearly associated with mortality in elderly hip fractures, and cholinesterase was a risk indicator of all-cause mortality.

Study context

Population
Elderly patients with hip fractures screened Jan 2015–Sep 2019
Participants
2,387 patients
Exposure
Preoperative serum cholinesterase level
Outcome
All-cause mortality
Follow-up
Mean 37.64 months
Methodological detailsmultivariate Cox regression, nonlinear analysis, propensity score-matching sensitivity analysis
  • Multivariate Cox regression
  • Nonlinear analysis
  • Propensity score-matching sensitivity analysis

Main finding

As reported in the abstract

All-cause mortality per 1000 U/L increase in preoperative cholinesterase
Hazard ratio (95% CI)P value
Cholinesterase per 1000 U/L (linear)linear association unstable; nonlinearity identified
0.83(0.78–0.88)
P < 0.0001
Cholinesterase < 5940 U/L, per 1000 U/Lmortality decreased by 28% per 1000 U/L increase
0.72(0.66–0.79)
P < 0.0001
Cholinesterase > 5940 U/Lmortality no longer decreased with rise of cholinesterase
1.01(0.91–1.11)
P = 0.9157

Each row per its own increment, as printed

Inflection point of cholinesterase concentration
5940 U/L
Deaths from all causes
787 (33.0%)

Observational data: associations, not effects.

Further findings

Nonlinear association, propensity score-matching sensitivity analysis

Nonlinear association very stable

Original publication

The association between preoperative serum cholinesterase and all-cause mortality in geriatric patients with hip fractures: a cohort study of 2387 patients. Perioper Med (Lond). Published 24 July 2024. doi:10.1186/s13741-024-00443-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.